Výsledky vyhledávání - "Chitra Tirodkar"

Subcutaneous C.E.R.A. for the Maintenance Treatment of Anemia in Pediatric Patients With CKD: A Phase 2, Open-Label, Single-Arm, Multicenter Study

Autor: Bradley A, Warady, Sylvie Meyer, Reigner, Chitra, Tirodkar, Dorota, Drozdz

Publikováno v: American Journal of Kidney Diseases. 81:684-694.e1

The optimum starting dose of intravenous continuous erythropoietin receptor activator (C.E.R.A.) has been previously determined; this study ascertains the optimum starting dose of subcutaneous (SC) C.E.R.A. administration in pediatric patients.Phase

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::28d38bd3d5405e1efec788d484eeb076
https://doi.org/10.1053/j.ajkd.2022.11.006

Zobrazit plný text záznamu

FC037: A Study to Ascertain the Optimum Starting Dose of Subcutaneous (SC) C.E.R.A. for Maintenance Treatment of Anemia in Pediatric Patients with Chronic Kidney Disease (CKD) on Dialysis or not yet on Dialysis

Autor: Bradley Warady, Sylvie Meyer Reigner, Chitra Tirodkar, Dorota Drozdz

Publikováno v: Nephrology Dialysis Transplantation. 37

BACKGROUND AND AIMS The Phase II study DOLPHIN (NH19707; NCT00717366) demonstrated that pediatric patients with chronic kidney disease (CKD) on hemodialysis can be safely and effectively switched from maintenance treatment with epoetin alfa/beta or d

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::c1590ae3d8eb93d4ad98cee5744ae3ce
https://doi.org/10.1093/ndt/gfac103.001

Zobrazit plný text záznamu

Periodical

Reports Outline Anemia Study Findings from Children's Mercy Kansas City (Subcutaneous Cera for the Maintenance Treatment of Anemia In Pediatric Patients With Ckd: a Phase 2, Open-label, Single-arm, Multicenter Study).

Publikováno v: Hematology Week; 7/28/2023, p216-216, 1p

Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání